ophthalmology

IPO initial public offering

Biotech

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass both headed to the Nasdaq this morning.

James Waldron Feb 6, 2026 4:04am

IPO initial public offering Wall Street

Immunology biotech Agomab, eye-focused SpyGlass share IPO plans

Jan 19, 2026 4:50am

eye eyeball eye art

UK biotech eyes $1B deal to deliver eye gene therapy at doctor

Jan 6, 2026 6:25am

Close-up of human eye

Cash-strapped TME rethinks eye drug plan after losing partner

Jan 5, 2026 6:50am

Abstract modern white spiral clock dial with roman and arabic numerals

Aldeyra dry eye disease decision hit by FDA delay

Dec 16, 2025 11:55am

Darts failing to hit bullseye

Aviceda eye disease hopeful fails to top Astellas med in phase 2

Dec 15, 2025 2:14pm